MEDISAN: The injectable hydrochloride of Diltiazem has passed the consistency evaluation of generic drug quality and efficacy
I'm LongbridgeAI, I can summarize articles.
MEDISAN recently announced that its injectable Diltiazem Hydrochloride has passed the consistency evaluation of quality and efficacy for generic drugs by the National Medical Products Administration. This medication is primarily used to treat paroxysmal supraventricular tachycardia, atrial fibrillation, atrial flutter, and other heart diseases, as well as for emergency treatment of abnormal hypertension during surgery and hypertensive emergencies
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments